Loading…
Loading…
Is competition picked up in general even outside of that? Or is Howden really a one-off
Are you seeing that in specific lines? Or is it more prevalent? And what are your expectations for that -- for the move of exposures from the E&S market to standard over the next year or so?
To what extent do you think it's the beginning of a trend given the favorable market backdrop that you have?
how do you think about like the weaker investment performance that you've seen recently factoring into your net flow expectations over the next year?
Is it reasonable to assume flows turning positive in the next few quarters, or is it sort of hard to say given market volatility or other factors?
You're almost at the level you had in all of last year through the first half of the year. So not sure if your guidance is overly conservative
Your comments on the pipeline have been generally constructive, but flows were weak across all of those businesses
Has there been a change in your view on how you approach the business versus this before?
the flows have been negative for the past 3 years because of some of the things you discussed on the call earlier. Is it reasonable to assume that there's not going to be a major change
you've been in the process of repricing your dental book, I think, a couple of years now. But should we assume that that's done completely?